adc

Documents about adc

• Mapping the Intratumoral and Peritumoral Microenvironment: Multilayered Shell ADC Analysis and Its Association with Multiparametric Biomarkers in Invasive Breast Cancer.#140754NCBI PubMed Central
• Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors#878118ClinicalTrials.gov
• A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors#966715ClinicalTrials.gov
• A cryogenic readout integrated circuit with analog pile-up and in-Pixel ADC for high frame rate Skipper CCD-in-CMOS Sensors#623182arXiv (OAI Expanded)
• A cryogenic readout integrated circuit with analog pile-up and in-Pixel ADC for high frame rate Skipper CCD-in-CMOS Sensors#625455arXiv (All)
• Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)#813021ClinicalTrials.gov
• RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2#909294ClinicalTrials.gov
• Evaluation of peripheral zone prostate cancer aggressiveness using the ratio of diffusion tensor imaging measures#954918Koc University Digital Collections
• Highly Efficient 3-in-1 FPGA-Based Unit Combining an ADC, DAC, and Multichannel Pulse Generator for Pulsed EPR Spectroscopy#618885arXiv (OAI Expanded)
• Highly Efficient 3-in-1 FPGA-Based Unit Combining an ADC, DAC, and Multichannel Pulse Generator for Pulsed EPR Spectroscopy#620564arXiv (All)
• A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.#824922ClinicalTrials.gov
• A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.#849733ClinicalTrials.gov
• Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.#854355ClinicalTrials.gov
• Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma#876944ClinicalTrials.gov
• Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids#303746ClinicalTrials.gov
• Raw data for: "Nuclear Quantum Effects Have a Significant Impact on UV/Vis Absorption Spectra of Chromophores in Water"#466462TUDOdata Dataverse OAI Archive
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors#841801ClinicalTrials.gov
• A Study Of PF-06647263 In Patients With Advanced Solid Tumors#844872ClinicalTrials.gov
• Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer#861926ClinicalTrials.gov
• El Programa de Producción y su Relación en la Gestión de Inventarios de Corporación ADC Sede Tacna, Periodo 2014-2016#1041149Repositorio Institucional
• Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia#805796ClinicalTrials.gov
• Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma#850027ClinicalTrials.gov
• Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer#879611ClinicalTrials.gov
• Artificial intelligence for lung cancer classification in cytology specimens: A systematic review and diagnostic test accuracy meta-analysis of benign-malignant diagnosis and ADC/SCC/SCLC subtyping.#666072NCBI PubMed Central
• A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway#854177ClinicalTrials.gov
• Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II#909046ClinicalTrials.gov
• Long-term Registry of Patients Treated With Loncastuximab Tesirine#916938ClinicalTrials.gov
• Retinomorphic mid-wave infrared in-sensor processing engine: device-to-architecture co-design#405391Digital Commons @ NJIT
• PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors#895346ClinicalTrials.gov
• Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma#995009ClinicalTrials.gov
• Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2#148778ClinicalTrials.gov
• Programa de inducción y reinducción para los empleados de ADC & Has Management Ecuador#396902Repositorio de la Pontificia Universidad Católica del Ecuador
• A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN#837251ClinicalTrials.gov
• A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.#859836ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma#872824ClinicalTrials.gov
• Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology#979305ClinicalTrials.gov
• Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer#825079ClinicalTrials.gov
• Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer#872456ClinicalTrials.gov
• A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer#853789ClinicalTrials.gov
• A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors#1009079ClinicalTrials.gov
• A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer#874921ClinicalTrials.gov
• A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy and Safety of Trilaciclib in Preventing Myelosuppression Caused by Topoisomerase I Inhibitor Type ADC Drugs#887087ClinicalTrials.gov
• CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)#895495ClinicalTrials.gov
• Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma#866136ClinicalTrials.gov
• A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer#968863ClinicalTrials.gov
• Hormonal Influences on ADC Values in Breast Tissues: A Scoping Review of DWI in Pre- and Post-menopausal Women [version 3; peer review: 2 approved]#20353DOAJ
• A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer#876485ClinicalTrials.gov
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)#869163ClinicalTrials.gov
• A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer#855003ClinicalTrials.gov
• A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors#882679ClinicalTrials.gov